Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × Vinorelbine × Clear all

Sponsor

Conditions

Breast Neoplasms 35 Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 9 Neoplasm Metastasis 6 Hodgkin Disease 6 Neoplasms 4 Recurrence 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma 2 Mesothelioma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Carcinoma 2 Breast Neoplasms, Male 2 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Pleural Effusion, Malignant 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non - Small Cell Lung Cancer NSCLC 1 Neuroendocrine Tumors 1 Neuralgia 1 Metatropic dwarfism 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Locally Advanced Non-Small Cell Lung Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Desmoplastic Small Round Cell Tumor 1

Interventions

Gemcitabine 42 Cisplatin 29 pembrolizumab 25 Paclitaxel 12 Docetaxel 12 atezolizumab 11 Nivolumab 10 Mitomycin 10 avelumab 9 Carboplatin 9 Cystectomy 8 durvalumab 7 Sunitinib 7 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 apaziquone 5 Vinblastine 5 Platinum 5 Methotrexate 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4 vinflunine 3 tisotumab vedotin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡